| Product NDC: | 0004-0357 | 
| Proprietary Name: | Pegasys | 
| Non Proprietary Name: | peginterferon alfa-2a | 
| Active Ingredient(s): | 180 ug/.5mL & nbsp; peginterferon alfa-2a | 
| Administration Route(s): | SUBCUTANEOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0357 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | BLA103964 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 20110329 | 
| Package NDC: | 0004-0357-30 | 
| Package Description: | 1 PACKET in 1 BOX (0004-0357-30) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS | 
| NDC Code | 0004-0357-30 | 
| Proprietary Name | Pegasys | 
| Package Description | 1 PACKET in 1 BOX (0004-0357-30) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS | 
| Product NDC | 0004-0357 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | peginterferon alfa-2a | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | SUBCUTANEOUS | 
| Start Marketing Date | 20110329 | 
| Marketing Category Name | BLA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | PEGINTERFERON ALFA-2A | 
| Strength Number | 180 | 
| Strength Unit | ug/.5mL | 
| Pharmaceutical Classes | Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] |